News

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
A. Baur & Co. Ltd., widely known as Baurs, a leading conglomerate with diversified business interests in Sri Lanka and a ...
Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...
Cofounder and CEO Jareeporn Jarukornsakul built industrial parks developer WHA from the ground up. Now she’s facing the ...
When the success of medicine itself is directly ... witnessed large-scale pharma initiatives for social impact, such as GlaxoSmithKline’s £1 billion R&D initiative developing vaccines in ...
The Times says government officials are "scrambling" to save the pharmaceutical industry from tariffs. It reports that President Donald Trump has suggested duties of 25% on foreign drugs, which could ...
Some manufacturing companies that have discontinued operations in Nigeria are GlaxoSmithKline (GSK), Procter & Gamble ... "For instance, admirable success has been recorded in the area of security.
GlaxoSmithKline has found a replacement for ... His time at Pfizer has coincided with the spectacular success of its BioNTech-partnered mRNA vaccine for COVID-19 – Comirnaty – and as GSK ...
Cork’s pharmaceutical industry, vital to the local economy, is at risk as US trade policies threaten small towns reliant on ...